UPDATE : Friday, July 10, 2020
상단여백
Bridge Biotherapeutics scores regulatory nod for trial of NSCLC treatment by Lee Han-soo 2020-05-08 15:45
Celltrion Healthcare launches Remsima SC in Netherlands by Lee Han-soo 2020-05-07 14:53
Cellivery sure to win licensing deal with top pharma company by Jeong Sae-im 2020-05-07 11:27
Theragen Bio starts as independent company by Shim Hyun-tai 2020-05-06 17:24
Kolon begins testing gene therapy for neuropathic pain in US by Jeong Sae-im 2020-04-27 16:18
라인
Pharmicell’s sales to rise with commercial supply of mPEG by Shim Hyun-tai 2020-04-24 18:10
Herzuma wins 40% of market share in Japan by Shim Hyun-tai 2020-04-21 16:42
‘Stem cell therapy more effective on Covid-19’ by Jeong Sae-im 2020-04-21 11:01
‘Natural Killer cells predict immunotherapy’s efficacy in lung cancer patients’ by Jeong Sae-im 2020-04-17 16:07
Samsung Bioepis launches anticancer biosimilar in US by Shim Hyun-tai 2020-04-16 17:32
라인
What are the odds for successful Invossa trials in US? by Jeong Sae-im 2020-04-14 15:01
Celltrion gets antibody candidates neutralizing new coronavirus by Shim Hyun-tai 2020-04-13 18:16
FDA OKs resumption of phase-3 Invossa trial in US by Jeong Sae-im 2020-04-13 11:58
Samsung signs contract with Vir to make COVID-19 treatment by Shim Hyun-tai 2020-04-10 18:07
No Korean firms have entered trials to test COVID-19 drug candidates by Jeong Sae-im 2020-04-08 16:15
라인
Samsung Biologics signs CDO contract with PharmAbcine by Shim Hyun-tai 2020-04-06 18:00
AbClon draws many new human antibodies to fight COVID-19 by Shim Hyun-tai 2020-03-30 17:47
ImmuneMed under fire for inflating drug’s effect against COVID-19 by Jeong Sae-im 2020-03-27 11:49
Warrant sought to arrest Medytox CEO for illegally making, selling Meditoxin by Jeong Sae-im 2020-03-25 14:09
Will next-generation COVID-19 tests replace standard PCR checks? by Jeong Sae-im 2020-03-25 11:40
여백
여백
여백
Back to Top